Cytovale™ Receives Distinguished Abstract Award from AACC for Evaluation of Sepsis Assay Cytovale™ Receives Distinguished Abstract Award from AACC for Evaluation of Sepsis Assay Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics using cell mechanics and machine learning, has received an AACC Academys Distinguished Abstract Award for its abstract titled Rapidly Assessing the Host Immune Response for the Diagnosis of Sepsis, a Prospective Multi-Site Clinical Study in the Emergency Department (ED) Employing the Leukocyte Structural Index (LSI). The LSI “ Cytovales IntelliSep test “ is an investigational, pathogen-agnostic direct assessment of white blood cell activation, which allows for rapid quantification of host immune response in an acute care setting. It utilizes routine blood draw samples, requiring minimal operator handling, and achieves a blood-to-answer turnaround time of less than 10 minutes.